Bionano Genomics Inc (BNGO)
0.4632
+0.02
(+4.94%)
USD |
NASDAQ |
Sep 27, 16:00
0.4726
+0.01
(+2.03%)
After-Hours: 20:00
Bionano Genomics SG&A Expense (TTM): 71.68M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 71.68M |
March 31, 2024 | 87.06M |
December 31, 2023 | 93.50M |
September 30, 2023 | 103.13M |
June 30, 2023 | 99.45M |
March 31, 2023 | 94.30M |
December 31, 2022 | 88.60M |
September 30, 2022 | 83.08M |
June 30, 2022 | 77.19M |
March 31, 2022 | 69.24M |
December 31, 2021 | 58.49M |
September 30, 2021 | 48.11M |
June 30, 2021 | 41.44M |
March 31, 2021 | 33.23M |
Date | Value |
---|---|
December 31, 2020 | 31.07M |
September 30, 2020 | 27.50M |
June 30, 2020 | 23.29M |
March 31, 2020 | 22.73M |
December 31, 2019 | 20.16M |
September 30, 2019 | 18.90M |
June 30, 2019 | 17.67M |
March 31, 2019 | 16.11M |
December 31, 2018 | 14.21M |
September 30, 2018 | 13.14M |
June 30, 2018 | 13.03M |
March 31, 2018 | 13.46M |
December 31, 2017 | 14.08M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
18.90M
Minimum
Sep 2019
103.13M
Maximum
Sep 2023
59.61M
Average
63.87M
Median
SG&A Expense (TTM) Benchmarks
Revvity Inc | 1.019B |
Bruker Corp | 805.40M |
Azenta Inc | 305.65M |
Harvard Bioscience Inc | 45.99M |
Akoya Biosciences Inc | 76.87M |